Clinical trials

  • SURABGENE LOMPARVOVEC for Neovascular age-related macular degeneration
  • AMOXICILLIN for Community-acquired pneumonia
  • Obinutuzumab for Lupus nephritis | Systemic lupus erythematosus
  • INCB000928 for Anemia due to myelofibrosis
  • Clinical trial in Multiple myeloma
  • Clinical trial in Triple-negative breast cancer | Early relapsed metastatic breast cancer
  • EMPAGLIFLOZIN for Cardiogenic shock
  • ABBV-101 for B-cell malignancies | Non-Hodgkin B-cell lymphoma
  • Atezolizumab for Early HER2-positive breast cancer
  • C1 ESTERASE INHIBITOR (HUMAN) for Hereditary angioedema | Hereditary angioedema type I | Hereditary angioedema type II | Acute hereditary angioedema attack
  • Mepivacaine hydrochloride for Postoperative pain
  • pembrolizumab for Metastatic non-squamous non-small cell lung cancer|Non-small cell lung cancer